收费全文 | 95424篇 |
免费 | 7258篇 |
国内免费 | 214篇 |
耳鼻咽喉 | 759篇 |
儿科学 | 3707篇 |
妇产科学 | 3004篇 |
基础医学 | 12537篇 |
口腔科学 | 1550篇 |
临床医学 | 14986篇 |
内科学 | 17857篇 |
皮肤病学 | 1631篇 |
神经病学 | 9185篇 |
特种医学 | 1930篇 |
外国民族医学 | 33篇 |
外科学 | 8379篇 |
综合类 | 1006篇 |
一般理论 | 140篇 |
预防医学 | 12556篇 |
眼科学 | 1209篇 |
药学 | 5398篇 |
3篇 | |
中国医学 | 139篇 |
肿瘤学 | 6887篇 |
2023年 | 708篇 |
2022年 | 995篇 |
2021年 | 2198篇 |
2020年 | 1567篇 |
2019年 | 2414篇 |
2018年 | 2695篇 |
2017年 | 2015篇 |
2016年 | 2253篇 |
2015年 | 2389篇 |
2014年 | 3158篇 |
2013年 | 4948篇 |
2012年 | 6953篇 |
2011年 | 7302篇 |
2010年 | 3946篇 |
2009年 | 3600篇 |
2008年 | 6185篇 |
2007年 | 6687篇 |
2006年 | 6518篇 |
2005年 | 6227篇 |
2004年 | 6057篇 |
2003年 | 5663篇 |
2002年 | 5204篇 |
2001年 | 732篇 |
2000年 | 522篇 |
1999年 | 695篇 |
1998年 | 1144篇 |
1997年 | 892篇 |
1996年 | 773篇 |
1995年 | 686篇 |
1994年 | 628篇 |
1993年 | 618篇 |
1992年 | 431篇 |
1991年 | 382篇 |
1990年 | 361篇 |
1989年 | 282篇 |
1988年 | 297篇 |
1987年 | 272篇 |
1986年 | 246篇 |
1985年 | 278篇 |
1984年 | 306篇 |
1983年 | 304篇 |
1982年 | 386篇 |
1981年 | 367篇 |
1980年 | 287篇 |
1979年 | 198篇 |
1978年 | 177篇 |
1977年 | 178篇 |
1976年 | 155篇 |
1975年 | 126篇 |
1973年 | 118篇 |
Introduction
In the phase II/III KEYNOTE-010 study (ClinicalTrials.gov, NCT01905657), pembrolizumab significantly prolonged overall survival over docetaxel in patients with previously treated, programmed death ligand 1–expressing (tumor proportion score ≥ 1%), advanced NSCLC. Health-related quality of life (HRQoL) results are reported here.Methods
Patients were randomized 1:1:1 to pembrolizumab 2 or 10 mg/kg every 3 weeks or docetaxel 75 mg/m2 every 3 weeks. HRQoL was assessed using European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLC) Core 30 (C30), EORTC QLQ–Lung Cancer 13 (LC13), and EuroQoL-5D. Key analyses included mean baseline-to-week-12 change in global health status (GHS)/quality of life (QoL) score, functioning and symptom domains, and time to deterioration in a QLQ-LC13 composite endpoint of cough, dyspnea, and chest pain.Results
Patient reported outcomes compliance was high across all three instruments. Pembrolizumab was associated with better QLQ-C30 GHS/QoL scores from baseline to 12 weeks than docetaxel, regardless of pembrolizumab dose or tumor proportion score status (not significant). Compared with docetaxel, fewer pembrolizumab-treated patients had “deteriorated” status and more had “improved” status in GHS/QoL. Nominally significant improvement was reported in many EORTC symptom domains with pembrolizumab, and nominally significant worsening was reported with docetaxel. Significant prolongation in true time to deterioration for the QLQ-LC13 composite endpoint emerged for pembrolizumab 10 mg/kg compared to docetaxel (nominal two-sided p = 0.03), but not for the 2-mg/kg dose.Conclusions
These findings suggest that HRQoL and symptoms are maintained or improved to a greater degree with pembrolizumab than with docetaxel in this NSCLC patient population. 相似文献Method: Thirty-two pediatric patients with stroke (Mage = 9.5 ± 2.7 years) and 32 demographically equivalent, healthy controls were tested on standardized measures of arithmetic, spelling, and intelligence. Executive functioning data were collected via standardized parent questionnaire.
Results: Relative to controls, stroke participants demonstrated significantly poorer functioning in math, spelling, metacognition, and behavioral-regulation. Pencil and paper arithmetic was particularly challenging for the stroke group, with 40% of patients reaching levels of clinical impairment. Hierarchical regression in stroke participants further revealed that metacognition was a robust predictor of academic deficits. Stroke occurring in later childhood and affecting cortical and subcortical brain regions also presented as potential clinical risk factors.
Conclusions: Children with stroke were especially vulnerable to math achievement deficits. Metacognition made a substantial contribution to academic achievement abilities among stroke patients, and results underscore the importance of early metacognitive skills in the completion of schoolwork. Results also emphasize that pediatric stroke patients are a heterogeneous group with regard to functioning and that there is value in examining standard score distributions of clinical participant samples. 相似文献
A key goal for implementation science is the identification of evidence-based consultation protocols and the active ingredients within these protocols that drive clinician behavior change. The current study examined clinicians’ self-coding of fidelity as a potential active ingredient of consultation for the Attachment and Biobehavioral Catch-up (ABC) intervention. It also examined two other potential predictors of clinician fidelity in response to consultation: dosage of consultation and working alliance. Twenty-nine clinicians (97% female, 62% White, M age?=?34 years) participated in a year of weekly fidelity-focused ABC consultation sessions, for which clinicians self-coded fidelity and received consultant feedback on both their coding and their fidelity. Data from the ABC fidelity measure were available for 1067 sessions coded by consultants, and clinicians’ self-coding accuracy was calculated from 1044 sessions coded by both clinicians and consultants. Alliance was measured with the Working Alliance Inventory—Trainee and Supervisor Versions. The study was observational, and fidelity and self-coding accuracy were modeled across time using hierarchical linear modeling. Clinicians’ ABC fidelity, as well as their self-coding accuracy, increased over the course of consultation. Clinicians’ self-coding accuracy predicted their initial fidelity and growth in fidelity. Working alliance was also linked to fidelity and self-coding accuracy. These results suggest that clinician self-coding should be further examined as an active ingredient of consultation. The study has important implications for the design of consultation procedures and fidelity assessments.
相似文献